Molecular Architecture and Catalytic Mechanisms of Class D Carbapenemases: Insights into Antibiotic Resistance and Carbapenem Design
ACS Infectious Diseases · 11.09.2026 · 12 (9) · 2965-2984
DOI: 10.1021/acsinfecdis.6c00611 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Infectious Diseases, online erschienen am 26.08.2026. Verfasst von Clyde A Smith und 3 weiteren Autor:innen. Beteiligte Einrichtung: Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, Menlo Park, California94025, United States. Hauptthemen laut MEDLINE: beta-Lactamases, Carbapenems, Bacterial Proteins, Anti-Bacterial Agents. Die Arbeit nennt 149 Literaturangaben. Gefördert von: NIGMS NIH HHS, National Institute of Allergy and Infectious Diseases, Biological and Environmental Research.
Abstract (Originalsprache)
The β-lactam class of antibiotics remains indispensable for treating bacterial infections, yet their effectiveness is increasingly compromised by the emergence of carbapenem-hydrolyzing class D β-lactamases, the principal mechanism of carbapenem resistance in Acinetobacter baumannii and an important contributor to resistance in Enterobacterales. This review focuses on the structural biology and enzymatic mechanisms of these enzymes, with particular emphasis on the post-translationally carboxylated Lys73 and the solvent-restricted pocket that encloses this residue. This pocket maintains the lysine in its catalytically essential carboxylated state, enabling it to function as the general base during both acylation and deacylation. A unique gating mechanism enables the entry of a deacylating water into the catalytic lysine pocket via the opening of a hydrophobic cap induced by the 6α-hydroxyethyl group of the carbapenem following acylation of the enzyme. These insights provide a mechanistic framework for the development of next-generation therapeutics capable of overcoming carbapenem resistance. Recently designed carbapenem derivatives perturb carboxylation of the catalytic lysine or disrupt proper positioning of the catalytic water in the active site, which severely impairs deacylation and results in potent inhibition of CHDLs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, Menlo Park, California94025, United States.
- Department of Chemistry, Stanford University, Stanford, California94303, United States.
- Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana46556, United States.
ORCID-Profile: Clyde A Smith, Sergei B Vakulenko
Förderung
- NIGMS NIH HHS
- National Institute of Allergy and Infectious Diseases
- Biological and Environmental Research
- National Institute of General Medical Sciences
Zitieren
APA
Smith, C. A., Toth, M., Stewart, N. K., & Vakulenko, S. B. (2026). Molecular Architecture and Catalytic Mechanisms of Class D Carbapenemases: Insights into Antibiotic Resistance and Carbapenem Design. ACS Infectious Diseases, 12(9), 2965-2984. https://doi.org/10.1021/acsinfecdis.6c00611
Vancouver
Smith CA, Toth M, Stewart NK, Vakulenko SB. Molecular Architecture and Catalytic Mechanisms of Class D Carbapenemases: Insights into Antibiotic Resistance and Carbapenem Design. ACS Infectious Diseases. 2026;12(9):2965-2984. doi:10.1021/acsinfecdis.6c00611
BibTeX
@article{Smith2026,
author = {Smith, Clyde A and Toth, Marta and Stewart, Nichole K and Vakulenko, Sergei B},
title = {Molecular Architecture and Catalytic Mechanisms of Class D Carbapenemases: Insights into Antibiotic Resistance and Carbapenem Design},
journal = {ACS Infectious Diseases},
year = {2026},
volume = {12},
number = {9},
pages = {2965--2984},
doi = {10.1021/acsinfecdis.6c00611}
}
EUVIMED